[ad_1] 3-Year CAGR Targets[1]: High-Single-Digit Operating Profit[2], Double‑Digit Diluted EPS[3] and Double-Digit Free Cash Flow Per Share[4] On Track to Reach 20,000 Stores by 2026, and Accelerating to over 30,000 Stores by 2030 Front-end Diversification, […]
Tag: Inc.
Akeso’s Bispecific Antibody Targeting Aβ and BBB-Expressed Receptor Approved for Alzheimer’s Disease Clinical Trials in China
[ad_1] HONG KONG, Nov. 16, 2025 /PRNewswire/ — Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by […]
BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson’s Disease at the 2025 Society for Neuroscience Annual Meeting
[ad_1] SAN DIEGO, Nov. 15, 2025 /PRNewswire/ — BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, highlighting new breakthroughs in […]
Public Service Company of New Mexico Declares Preferred Dividend
[ad_1] ALBUQUERQUE, N.M., Nov. 14, 2025 /PRNewswire/ — The Board of Directors of Public Service Company of New Mexico, a subsidiary of TXNM Energy (NYSE: TXNM), declared the regular quarterly dividend of $1.145 per share on the […]
Conrad Industries Announces Third Quarter 2025 Results and Backlog
[ad_1] MORGAN CITY, La., Nov. 14, 2025 /PRNewswire/ — Conrad Industries, Inc. (OTCID: CNRD) announced today its third quarter and nine months ended September 30, 2025 financial results and backlog at September 30, 2025. For […]
